Furthermore, the upregulation of MMP-2, MMP-3, and myeloperoxidase highlights the role of these tumors in host-immune interactions, while the decrease in osteopontin and proliferin suggests a shift toward a less favorable tumor microenvironment. The gene discussed is SPP1; the disease is neoplasm.